GAD65 autoantibodies can be observed at high titres in patients with a clinical spectrum of neurological syndromes encompassing stiff-person syndrome, cerebellar ataxia, LE, and drug-resistant TLE. The gene discussed is GAD2; the disease is cerebellar ataxia.